Peroxisomal and mitochondrial beta-oxidation are two principal pathways of fatty acid oxidation which regulate the nature and concentration of intracellular acyl-CoA and energy rich molecules. The integration of these two systems permits the animal to adapt to a wide range of nutrient composition without suffering from hyperglycemia or hyperlipidemia. This application proposes to investigate the role of these two pathways in the adaptation to nutrient composition and in the development of obesity and diabetes in the Zucker obese and diabetes model.
Specific Aim 1 : Test the hypothesis that the contribution of peroxisomal and mitochondrial beta-oxidation varies depending on the chain length and desaturation of the fatty acid (nutrient specific).
Specific Aim 2 : Test the hypothesis that two hormonal systems (insulin and leptin) affect fatty acid synthesis and oxidation differently to regulate gluconeogenesis and lipogenesis.
Specific Aim 3 : To examine peroxisomal and mitochondrial oxidation in obesity and diabetes using Zucker obese and Zucker diabetic models.
Specific Aim 4 : To test the hypothesis that the effect of PPAR ligands on fatty acid oxidation interacts with the leptin receptor signaling pathway to improve both glucose and lipid metabolism. A key feature of this proposal is the use of [1-13C]- and [U-13C]-fatty acids and mass spectral technologies to determine the relative contributions to the acetyl-CoA pool from fatty acyl chain shortening and elongation (peroxisomes) to mitochondrial beta-oxidation. These studies should provide new conceptual and experimental tools for the study of fatty acid oxidation regulation, a central issue in the pathophysiology of obesity and Type II diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056090-02
Application #
6381576
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
2000-08-15
Project End
2004-07-31
Budget Start
2001-08-01
Budget End
2002-07-31
Support Year
2
Fiscal Year
2001
Total Cost
$208,990
Indirect Cost
City
Torrance
State
CA
Country
United States
Zip Code
90502
Selivanov, Vitaly A; Marin, Silvia; Lee, Paul W N et al. (2006) Software for dynamic analysis of tracer-based metabolomic data: estimation of metabolic fluxes and their statistical analysis. Bioinformatics 22:2806-12
Xu, Jun; Gowen, Lori; Raphalides, Christian et al. (2006) Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse. Diabetes 55:3372-80
Marin, Silvia; Lee, W-N Paul; Bassilian, Sara et al. (2004) Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. Biochem J 381:287-94
Wong, Derek A; Bassilian, Sara; Lim, Shu et al. (2004) Coordination of peroxisomal beta-oxidation and fatty acid elongation in HepG2 cells. J Biol Chem 279:41302-9
Selivanov, Vitaly A; Puigjaner, Joaquim; Sillero, Antonio et al. (2004) An optimized algorithm for flux estimation from isotopomer distribution in glucose metabolites. Bioinformatics 20:3387-97
Xu, Jun; Chang, Vicky; Joseph, Sean B et al. (2004) Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology 145:1087-95
Xu, Jun; Lee, W N Paul; Xiao, Gary et al. (2003) Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test. Anal Biochem 315:238-46
Boren, Joan; Lee, Wai-Nang Paul; Bassilian, Sara et al. (2003) The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. J Biol Chem 278:28395-402
Bassilian, Sara; Ahmed, Syed; Lim, Shu K et al. (2002) Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am J Physiol Endocrinol Metab 282:E507-13
Xu, Jun; Xiao, Gary; Trujillo, Chuck et al. (2002) Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem 277:50237-44